Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating mild to moderate hypertension.

L J Tobin1

  • 1Hospital of the University of Pennsylvania, Philadelphia, USA.

The Nurse Practitioner
|June 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Idiopathic anaphylaxis and histamine dysregulation: Revisiting pathophysiologic assumptions.

The Nurse practitioner·2026
Same journal

Improving anxiety screening for adults with hypertension: An integrative review.

The Nurse practitioner·2026
Same journal

Modality matters: Standard of care in telehealth.

The Nurse practitioner·2026
Same journal

Updates in care for patients with genitourinary syndrome of menopause.

The Nurse practitioner·2026
Same journal

Updates in care for patients with genitourinary syndrome of menopause.

The Nurse practitioner·2026
Same journal

UpToDate®.

The Nurse practitioner·2026
See all related articles

Not all patients with borderline hypertension require drug therapy. Treatment decisions for hypertension should consider blood pressure levels, cardiovascular risk factors, and target organ damage, utilizing a risk stratification approach.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • The Sixth Report of the National Joint Committee on Prevention, Detection and Treatment of High Blood Pressure (JNC VI) established guidelines in 1997 for managing mild to moderate hypertension.
  • Concerns exist regarding potential increases in morbidity and mortality from pharmacotherapy in low-risk hypertensive patients.

Purpose of the Study:

  • To review the 1997 JNC VI guidelines for diagnosing, evaluating, and treating hypertension.
  • To emphasize a risk-stratification approach for treatment decisions in hypertensive patients.

Main Methods:

  • Review of the 1997 JNC VI hypertension management guidelines.
  • Analysis of treatment recommendations based on blood pressure levels and cardiovascular risk factors.

Related Experiment Videos

Main Results:

  • Pharmacotherapy may not be indicated for all patients with borderline hypertension, especially those at low risk for adverse cardiovascular outcomes.
  • Treatment decisions should integrate blood pressure readings with additional risk factors, existing cardiovascular disease, and evidence of target organ damage.

Conclusions:

  • The JNC VI guidelines advocate for a risk stratification strategy to tailor hypertension therapy.
  • Updated hypertension classifications, risk assessment, patient categorization, and initial/follow-up therapy recommendations are presented.